Cuorips Inc. is a startup company spun out of Osaka University, dedicated to the R&D and manufacturing of iPSC-derived regenerative medicine products. Driven by our slogan "SAVE YOUR HEART," we leverage proprietary technologies for manufacturing and purifying high-purity cardiomyocytes from iPS cells to advance the global commercialization of next-generation therapies and premium CDMO services.